BlackRock Japan’s Kindred Biosciences, Inc. KIN Stock Holding History

BlackRock Japan’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$9K	Sell	2,203 -396	-15%	-$1.92K	﹤0.01%	1229
2016 Q3	$13K	Sell	2,599 -728	-22%	-$3.08K	﹤0.01%	1186
2016 Q2	$12K	Buy	3,327 +35	+1%	+$129	﹤0.01%	1256
2016 Q1	$11K	Buy	3,292 +326	+11%	+$1.15K	﹤0.01%	1283
2015 Q4	$10K	Buy	+2,966	New	+$13.8K	﹤0.01%	1268
2015 Q2	–	Sell	-1,996	Closed	-$14K	–	1421
2015 Q1	$14K	Sell	1,996 -3,047	-60%	-$21K	﹤0.01%	1218
2014 Q4	$38K	Sell	5,043 -1,012	-17%	-$8.58K	﹤0.01%	1137
2014 Q3	$56K	Buy	+6,055	New	+$81.8K	﹤0.01%	1032

Other funds holding KIN

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

BlackRock Japan's KIN Position: Q4 2016 in Review

BlackRock Japan reduced its Kindred Biosciences, Inc. (KIN) stake by 15% in Q4 2016, selling an estimated $1.92K and leaving 2,203 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #1229.

BlackRock Japan first reported a position in KIN in Q3 2014 and has held it in 8 quarters since. The position peaked at $56K in Q3 2014. 43 funds tracked by Wall St. Rank hold KIN as of Q4 2016.

BlackRock Japan held 2,203 shares of Kindred Biosciences, Inc. worth $9K as of Q4 2016.
BlackRock Japan sold 396 Kindred Biosciences, Inc. shares in Q4 2016, an estimated $1.92K.
Kindred Biosciences, Inc. made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #1229 holding.
BlackRock Japan first reported a position in Kindred Biosciences, Inc. in Q3 2014 and has held it in 8 quarters since.
BlackRock Japan's Kindred Biosciences, Inc. position peaked at $56K in Q3 2014.
43 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.